Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis

Authors:
  • PMPatricia J. McLaughlin
    Patricia J. McLaughlin
  • IZIan S. Zagon
    Ian S. Zagon

Abstract
No abstract available
Funding Information
  • National Multiple Sclerosis Society

This publication has 49 references indexed in Scilit: